XML 20 R5.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Total Revenues $ 477,000 $ 931,000
Operating Expenses:    
Research and development 18,385,000 19,543,000
Selling, general and administrative 16,387,000 20,299,000
Total Operating Expenses 34,772,000 39,842,000
Operating Loss (34,295,000) (38,911,000)
Interest expense 0 (5,610,000)
Other income (expense), net 363,000 (135,000)
Loss from continuing operations before income taxes (33,932,000) (44,656,000)
Income tax expense (benefit) 13,000 (448,000)
Loss from continuing operations (33,945,000) (44,208,000)
Income (loss) from discontinued operations, net of income taxes 10,735,000 (29,121,000)
Net Loss $ (23,210,000) $ (73,329,000)
Loss per share from continuing operations, basic (in dollars per share) $ (10.65) $ (15.46)
Loss per share from continuing operations, diluted (in dollars per share) (10.65) (15.46)
(Loss) income per share from discontinuing operations, basic (in dollars per share) 3.37 (10.18)
(loss) income per share from discontinuing operations, diluted (in dollars per share) 3.37 (10.18)
Loss per share basic (in dollars per share) (7.28) (25.64)
Loss per share diluted (in dollars per share) $ (7.28) $ (25.64)
Weighted average shares outstanding - basic (in shares) 3,186 2,859
Weighted average shares outstanding - diluted (in shares) 3,186 2,859
Royalty revenues    
Total Revenues $ 477,000 $ 931,000